Main Content

Institutional Biosafety Committee Minutes

The Institutional Biosafety Committee is responsible for producing meeting minutes that sufficiently document biosafety review and oversight responsibilities. The IBC meeting minutes not only serve UMMCinstitution’s need for record of the IBC’s proceedings, but demonstrate to the National Institute of Health (NIH) and the public that the IBC is fulfilling its responsibilities under NIH guidelines to access and implement the necessary safety practices and containment procedures for basic and clinical research involving recombinant or synthetic nucleic acid molecules.

• IBC must adequately document fulfillment of their review and oversight responsibilities described in the NIH Guidelines
• The IBC minutes should offer sufficient detail to serve as a record of all major points of discussion and the committee’s rationale for particular discussions. Key points made in discussion, motions of the committee, and whether those motions were approved and documented.
• The IBC minutes should contain a brief summary of the proposed research. As part of the required risk assessment, minutes should include the following.
  • Type of research being proposed.
  • Any risks identified and details of the risk mitigation measures to be employed.
  • The biosafety level under which the research is approved plus any additional stipulations if necessary.
• September 2025
• October 2025
• November 2025
• December 2025
• January 2026